{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:40:12Z","timestamp":1794260412343,"version":"4.9.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymgme.2025.109189","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:00:41Z","timestamp":1751889641000},"page":"109189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2\/3 NPC-002 48-month open-label extension trial"],"prefix":"10.1016","volume":"145","author":[{"given":"Eugen","family":"Mengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia M.","family":"Da Riol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Del Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine Weller","family":"Gr\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Hennermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"H\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene","family":"Cording","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Himmelstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine \u00ed","family":"Dali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109189_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","article-title":"Lipids on trial: the search for the offending metabolite in Niemann-pick type C disease","volume":"11","author":"Lloyd-Evans","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.ymgme.2025.109189_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2019.108284","article-title":"The characteristics and biological significance of NPC2: mutation and disease","volume":"782","author":"Xu","year":"2019","journal-title":"Mutat Res Rev Mutat Res"},{"key":"10.1016\/j.ymgme.2025.109189_bb0020","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ymgme.2021.11.251","article-title":"Arimoclomol increases the transcription of lysosomal genes, including NPC1 and NPC2, to facilitate lysosomal function","volume":"135","author":"Petersen","year":"2022","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ymgme.2025.109189_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109103","article-title":"Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C disease","volume":"145","author":"Shammas","year":"2025","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ymgme.2025.109189_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40265-024-02129-x","article-title":"Arimoclomol: first approval","volume":"85","author":"Keam","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2025.109189_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jimd.12245","article-title":"Long-term survival outcomes of patients with Niemann-pick disease type C receiving miglustat treatment: a large retrospective observational study","volume":"43","author":"Patterson","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01363-2","article-title":"Treatment outcomes following continuous miglustat therapy in patients with Niemann-pick disease type C: a final report of the NPC registry","volume":"15","author":"Patterson","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0045","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-pick disease type C: results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","volume":"44","author":"Mengel","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-021-01719-2","article-title":"Validation of the 5-domain Niemann-pick type C clinical severity scale","volume":"16","author":"Patterson","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0055","first-page":"101233","article-title":"Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-pick disease type C (NPC): presenting a rescored 4-domain NPC clinical severity scale","volume":"43","author":"Mengel","year":"2025","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.ymgme.2025.109189_bb0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13023-020-01616-0","article-title":"Clinical disease progression and biomarkers in Niemann-pick disease type C: a prospective cohort study","volume":"15","author":"Mengel","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.ymgme.2025.109189_bb0070","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2025.109189_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-35","article-title":"Niemann-pick disease type C clinical database: cognitive and coordination deficits are early disease indicators","volume":"8","author":"Stampfer","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40265-025-02145-5","article-title":"Current and emerging therapies for lysosomal storage disorders","volume":"85","author":"Abelleyra Lastoria","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2025.109189_bb0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13023-021-02115-6","article-title":"International consensus on clinical severity scale use in evaluating Niemann\u2013Pick disease Type C in paediatric and adult patients: results from a Delphi Study","volume":"16","author":"Evans","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2025.109189_bb0090","doi-asserted-by":"crossref","first-page":"22621","DOI":"10.1038\/s41598-021-01966-0","article-title":"Estimated prevalence of Niemann-pick type C disease in Quebec","volume":"11","author":"Labrecque","year":"2021","journal-title":"Sci Rep"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:55:00Z","timestamp":1764834900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1096719225001805"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109189","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2\/3 NPC-002 48-month open-label extension trial","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109189"}}